《大行報告》富瑞下調滔搏(06110.HK)目標價至9.5元 評級「買入」
富瑞發表報告指,滔搏(06110.HK)公布截至5月底止首季銷售數據,並召開電話會議。季內銷售與2021年同期相比略有下降,反映銷售額在兩年基礎上略有下降,並與該行檢查結果一致。該行認為Nike內地線下業務在兩年基礎上略有增長,而Adidas內地線下業務則在兩年基礎上下降雙位數的百分點。
該行降低對滔搏收入和利潤率預測,以反映較弱的預期需求和促銷的零售環境。目標價由12.3元下調至9.5元,評級「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.